CORDIS
EU research results

CORDIS

English EN
Safety and efficacy for new techniques and imaging using new equipment to support European legislation.

Safety and efficacy for new techniques and imaging using new equipment to support European legislation.

Objective

Health services in the EU are a growing fraction of national wealth, typically 10% of GDP. Within this radiological imaging is gaining increasing prominence and now accounts for up to 10% of hospital revenue and 15% of capital equipment budgets, thereby identifying it as an investment of major social importance.This increase has been driven by new developments in equipment, digital imaging, medical devices, and IT industries; paralleled by novel clinical practices and modalities. Striking examples include the introduction of digital technologies to replace film, and the range of sophisticated angiographic techniques now used widely.This proposal deals with radiation protection, safety, and related issues that arise from these developments. It covers over 90% of patient examinations, 60% of the collective dose from medical sources, and approximately 50% of the collective dose from man-made sources.In practice this proposal deals with almost all radiological digital imaging outside of CT Scanning.This proposal is essential, as at present development is entirely driven by the combined and essentially global forces of the industry on one side, and the clinical users on the other.There has been no parallel investment in research on the protection, safety, efficacy, optimisation, justification, and ethical issues (despite a certain amount of regulatory development).This deficit is now evident, as day-to-day practice has outpaced the available statutory safety and standards framework. Undertaking the proposed programme, which spans: Functional and Objective Equipment Performance and International Standards Dosimetry,Constancy Testing and QA Justification,Ethics, and Efficacy Guidelines, Good Practice, and Training Materials will underwrite the safety, efficacy and ethical aspects of clinical practice, while protecting and adding value to the products and of the associated knowledge based equipment, devices, IT, and services industries.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

NORTHUMBERLAND, TYNE & WEAR STRATEGIC HEALTH AUTHORITY

Address

Riverside House, The Waterfront, Goldcrest Way, Newburn Riverside
Newcastle Upon Tyne

United Kingdom

Administrative Contact

Ruth O'BRIEN (Ms)

Participants (22)

Sort alphabetically

Expand all

THE HAUGHTON INSTITUTE FOR GRADUATE EDUCATION AND TRAINING IN THE HEALTH SCIENCES LIMITED

Ireland

BARMHERZIGE BRUDER TRIER E.V.

Germany

AZIENDA OSPEDALIERA SANTA MARIA DELLA MISERICORDIA

Italy

UNIVERSIDAD COMPLUTENSE DE MADRID

Spain

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

MEDIZINISCHE UNIVERSITAET INNSBRUCK

Austria

CENTRE DE RECHERCHE PUBLIC DE LA SANTE (CPR)

Luxembourg

SATEILYTURVAKESKUS - RADIATION AND NUCLEAR SAFETY AUTHORITY

Finland

TECHNISCHE UNIVERSITEIT DELFT

Netherlands

GENERAL REGIONAL HOSPITAL OF ATHENS

Greece

NOFER INSTITUTE OF OCCUPATIONAL MEDICINE

Poland

PHILANTHROPIKO IDRIMA VIOIATRIKON EREVNON

Cyprus

DUSAN SALAT

Slovakia

TARTU UELIKOOL

Estonia

ZAVOD ZA VARSTVOPRI DELU D.D.

Slovenia

ANKARA UNIVERSITESI

Turkey

UNIVERSITA DI PISA

Italy

NATIONAL CENTRE OF RADIOBIOLOGY AND RADIATION PROTECTION

Bulgaria

"FREDERIC JOLIOT CURIE" NATIONAL RESEARCH INSTITUTE FOR RADIOBIOLOGY AND RADIOHYGIENE - NATIONAL CENTER OF PUBLIC HEALTH

Hungary

LANARKSHIRE HEALTH BOARD

United Kingdom

INSTITUTUL DE SANATATE PUBLICA

Romania

NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS

Greece

Project information

Grant agreement ID: 12909

  • Start date

    1 February 2005

  • End date

    30 April 2007

Funded under:

FP6-EURATOM-RADPROT

  • Overall budget:

    € 714 400

  • EU contribution

    € 700 000

Coordinated by:

NORTHUMBERLAND, TYNE & WEAR STRATEGIC HEALTH AUTHORITY

United Kingdom